[HTML][HTML] The “usual suspects”: genes for inflammation, fibrosis, regeneration, and muscle strength modify Duchenne muscular dystrophy

L Bello, E Pegoraro - Journal of Clinical Medicine, 2019 - mdpi.com
Duchenne muscular dystrophy (DMD), the most severe form of dystrophinopathy, is quite
homogeneous with regards to its causative biochemical defect, ie, complete dystrophin …

Is it time for genetic modifiers to predict prognosis in Duchenne muscular dystrophy?

L Bello, EP Hoffman, E Pegoraro - Nature Reviews Neurology, 2023 - nature.com
Patients with Duchenne muscular dystrophy (DMD) show clinically relevant phenotypic
variability, despite sharing the same primary biochemical defect (dystrophin deficiency) …

Genetic modifiers of ambulation in the cooperative international Neuromuscular research group Duchenne natural history study

L Bello, A Kesari, H Gordish‐Dressman… - Annals of …, 2015 - Wiley Online Library
Objective We studied the effects of LTBP4 and SPP1 polymorphisms on age at loss of
ambulation (LoA) in a multiethnic Duchenne muscular dystrophy (DMD) cohort. Methods We …

Genetic modifiers of respiratory function in Duchenne muscular dystrophy

L Bello, G D'Angelo, M Villa, A Fusto… - Annals of clinical …, 2020 - Wiley Online Library
Objective Respiratory insufficiency is a major complication of Duchenne muscular dystrophy
(DMD). Its progression shows considerable interindividual variability, which has been less …

Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy

L Bello, L Piva, A Barp, A Taglia, E Picillo, G Vasco… - Neurology, 2012 - AAN Enterprises
Objective: To test the effect of the single nucleotide polymorphism− 66 T> G (rs28357094) in
the osteopontin gene (SPP1) on functional measures over 12 months in Duchenne muscular …

[HTML][HTML] Compensatory movements during functional activities in ambulatory children with Duchenne muscular dystrophy

J Martini, MC Voos, ME Hukuda… - Arquivos de neuro …, 2014 - SciELO Brasil
Objective: During the transitional phase (ambulatory to non-ambulatory), synergies
characterize the evolution of Duchenne muscular dystrophy (DMD). This study was …

[HTML][HTML] Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia

LW Bonham, NZR Steele, CM Karch, I Broce… - Scientific reports, 2019 - nature.com
The semantic variant of primary progressive aphasia (svPPA) is a clinical syndrome
characterized by neurodegeneration and progressive loss of semantic knowledge. Unlike …

SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy: predicting the severity of Duchenne muscular dystrophy: implications for …

T Kyriakides, E Pegoraro, RC Griggs, EP Hoffman… - Neurology, 2011 - AAN Enterprises
The utrophin protein is upregulated in DMD and its expression shows a positive correlation
with age at biopsy and time to becoming wheelchair bound. 3 It has been shown that this …

Genetic and clinical modifiers in Duchenne muscular dystrophy

A Fusto - 2019 - research.unipd.it
The skeletal muscle is a highly organized tissue, which comprises muscle fibres and
connective tissue. Each muscle fibre is a multinucleated post-mitotic cell, surrounded by the …

[PDF][PDF] Genetic modifiers of ambulation in the CINRG duchenne natural history study.

L Bello, A Kesari, HA Gordish-Dressman, A Cnaan… - core.ac.uk
Objective: We studied the effects of LTBP4 and SPP1 polymorphisms on age at loss of
ambulation (LoA) in a multiethnic Duchenne muscular dystrophy (DMD) cohort. Methods …